ECSP034541A - Formulacion de una solucion de inhalacion con una sal tiotropio - Google Patents

Formulacion de una solucion de inhalacion con una sal tiotropio

Info

Publication number
ECSP034541A
ECSP034541A EC2003004541A ECSP034541A ECSP034541A EC SP034541 A ECSP034541 A EC SP034541A EC 2003004541 A EC2003004541 A EC 2003004541A EC SP034541 A ECSP034541 A EC SP034541A EC SP034541 A ECSP034541 A EC SP034541A
Authority
EC
Ecuador
Prior art keywords
formulation
tiotropio
salt
inhalation solution
water
Prior art date
Application number
EC2003004541A
Other languages
English (en)
Inventor
Christel Schmelzer
Humke Barbara Niklaus
Petra Barth
Karin Drechsel
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of ECSP034541A publication Critical patent/ECSP034541A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/537—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Abstract

La presente invención se refiere a una formulación para inhalación exenta de gases propelentes de bromuro de tiotropio o monohidrato de bromuro de tiotropio, disuelto en agua o en una mezcla de agua y etanol, así como a los inhalables, exentos de gases propelentes, resultantes de ella.
EC2003004541A 2000-10-31 2003-04-07 Formulacion de una solucion de inhalacion con una sal tiotropio ECSP034541A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10054036 2000-10-31

Publications (1)

Publication Number Publication Date
ECSP034541A true ECSP034541A (es) 2003-05-26

Family

ID=7661723

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2003004541A ECSP034541A (es) 2000-10-31 2003-04-07 Formulacion de una solucion de inhalacion con una sal tiotropio

Country Status (39)

Country Link
EP (2) EP1333819B1 (es)
JP (1) JP4344135B2 (es)
KR (1) KR100853107B1 (es)
CN (2) CN100396285C (es)
AR (1) AR038764A1 (es)
AT (1) ATE373473T1 (es)
AU (2) AU2002221738B2 (es)
BG (1) BG66315B1 (es)
BR (1) BRPI0115076B8 (es)
CA (1) CA2426074C (es)
CY (1) CY1107825T1 (es)
CZ (1) CZ300794B6 (es)
DE (2) DE50113037D1 (es)
DK (1) DK1333819T3 (es)
EA (1) EA007604B1 (es)
EC (1) ECSP034541A (es)
EE (1) EE05314B1 (es)
ES (1) ES2294045T3 (es)
HK (1) HK1060524A1 (es)
HR (1) HRP20030338B1 (es)
HU (1) HU229411B1 (es)
IL (2) IL155538A0 (es)
ME (1) ME00244B (es)
MX (1) MXPA03003742A (es)
MY (1) MY138940A (es)
NO (1) NO332519B1 (es)
NZ (1) NZ526023A (es)
PE (1) PE20030092A1 (es)
PL (1) PL203316B1 (es)
PT (1) PT1333819E (es)
RS (1) RS50859B (es)
SA (1) SA01220482B1 (es)
SI (1) SI1333819T1 (es)
SK (1) SK286027B6 (es)
TW (1) TWI293885B (es)
UA (1) UA78690C2 (es)
UY (1) UY26989A1 (es)
WO (1) WO2002036104A2 (es)
ZA (1) ZA200302922B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10216036A1 (de) * 2002-04-11 2003-10-23 Boehringer Ingelheim Pharma Aerosolformulierung für die Inhalation enthaltend ein Tiotropiumsalz
CN1292748C (zh) * 2003-03-05 2007-01-03 南昌弘益科技有限公司 噻托溴铵吸入粉雾剂及其制备工艺
PT1682541E (pt) * 2003-11-03 2010-04-14 Boehringer Ingelheim Int Processo para a preparação de sais de tiotrópio
PL2083007T3 (pl) * 2003-11-03 2013-09-30 Boehringer Ingelheim Int Sole tiotropium, sposoby ich wytwarzania oraz zawierające je kompozycje farmaceutyczne
EP1881980B1 (en) 2005-05-02 2012-08-22 Boehringer Ingelheim International GmbH Novel crystalline forms of tiotropium bromide
EP2044967A1 (de) * 2007-10-01 2009-04-08 Boehringer Ingelheim Pharma GmbH & Co. KG Zerstäuber
CN104306361A (zh) * 2014-09-24 2015-01-28 万特制药(海南)有限公司 一种含噻托溴铵的吸入性溶液
CN111374963A (zh) * 2018-12-31 2020-07-07 天津药业研究院有限公司 一种用于吸入的噻托铵溶液剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
SG45171A1 (en) * 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
DE19536902A1 (de) * 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
DE19847968A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen

Also Published As

Publication number Publication date
KR20030060926A (ko) 2003-07-16
ZA200302922B (en) 2004-04-22
EE05314B1 (et) 2010-08-16
ME00244B (me) 2011-05-10
EP1333819A2 (de) 2003-08-13
HUP0301378A3 (en) 2005-12-28
UA78690C2 (uk) 2007-04-25
AU2173802A (en) 2002-05-15
HRP20030338B1 (en) 2011-09-30
HUP0301378A2 (hu) 2003-10-28
BRPI0115076B1 (pt) 2016-07-26
YU33003A (sh) 2006-05-25
HRP20030338A2 (en) 2005-04-30
DE10152521A1 (de) 2002-07-11
SA01220482B1 (ar) 2007-07-31
ES2294045T3 (es) 2008-04-01
SK286027B6 (sk) 2008-01-07
DE50113037D1 (de) 2007-10-31
WO2002036104A2 (de) 2002-05-10
SI1333819T1 (sl) 2007-12-31
WO2002036104A3 (de) 2002-08-01
BR0115076A (pt) 2003-07-29
PL203316B1 (pl) 2009-09-30
PE20030092A1 (es) 2003-03-24
KR100853107B1 (ko) 2008-08-21
UY26989A1 (es) 2002-06-20
NZ526023A (en) 2005-05-27
MEP40408A (en) 2011-02-10
EP1837021A3 (de) 2008-03-19
CN100396285C (zh) 2008-06-25
CA2426074C (en) 2008-12-23
IL155538A0 (en) 2003-11-23
HU229411B1 (en) 2013-12-30
RS50859B (sr) 2010-08-31
NO20031911L (no) 2003-04-29
CZ300794B6 (cs) 2009-08-12
MY138940A (en) 2009-08-28
CY1107825T1 (el) 2013-06-19
SK5272003A3 (en) 2003-10-07
TWI293885B (en) 2008-03-01
BG107727A (bg) 2004-11-30
ATE373473T1 (de) 2007-10-15
CZ20031486A3 (cs) 2003-08-13
HK1060524A1 (en) 2004-08-13
NO332519B1 (no) 2012-10-08
JP4344135B2 (ja) 2009-10-14
EA007604B1 (ru) 2006-12-29
EE200300203A (et) 2003-10-15
MXPA03003742A (es) 2004-10-15
CN101292964A (zh) 2008-10-29
EP1333819B1 (de) 2007-09-19
IL155538A (en) 2008-11-26
EP1837021A2 (de) 2007-09-26
JP2004512357A (ja) 2004-04-22
PT1333819E (pt) 2007-10-29
DK1333819T3 (da) 2007-12-03
AR038764A1 (es) 2005-01-26
BRPI0115076B8 (pt) 2021-05-25
AU2002221738B2 (en) 2007-01-11
BG66315B1 (bg) 2013-04-30
PL360405A1 (en) 2004-09-06
NO20031911D0 (no) 2003-04-29
CA2426074A1 (en) 2002-05-10
CN1473038A (zh) 2004-02-04
EA200300482A1 (ru) 2003-12-25

Similar Documents

Publication Publication Date Title
UY27740A1 (es) Nuevos compuestos
UY29047A1 (es) Derivados de sulfonamidas, su preparación y su aplicación en terapéutica
CO5640070A2 (es) Formulacion para un inhalador con dosis medida que emplea hidrofluoroalcanos como propulsores
EA200600620A1 (ru) Набор для ингаляции с ингаляционным порошком, содержащим тиотропий
CR7583A (es) Nueva sal formiato de o-desmetil venlafaxina
SG151254A1 (en) Substituted morpholine and thiomorpholine derivatives
CY1107825T1 (el) Εισπνεομενα σκευασματα τυπου διαλυματος με αλαστιοτροπιου
AR058163A1 (es) Medicamentos exhaltadores del deseo sexual que comprenden derivados de benzimidazolona
DE60334536D1 (de) Furylverbindungen
ECSP045221A (es) Sales de valsartan
ECSP034570A (es) Formulacion de una solucion de inhalacion con una sal tiotropio
UA93529C2 (ru) Соли и смеси 9-оксоакридин-10-уксусной кислоты c 1-алкиламино-1-дезоксиполиолами
ATE514698T1 (de) Tetracyclische azapyrazinoindoline als 5-ht2- liganden
IL179813A0 (en) S-tenatoprazole sodium monohydrate salt and use thereof in the form of a proton pump inhibitor
UY27324A1 (es) Nuevas sales de napsilato i
AR063597A1 (es) Nueva sal
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
AU2001285944A1 (en) Fungicidal agent containing n-chlorotaurine and use thereof
HN2001000021A (es) Nuevos derivados de amidas heterociclicas
BR0107483A (pt) Processo para a preparação de um composto
TR200603833T2 (tr) 7-karboksimetiloksi-3',4',5-trimetoksi flavon-monohidrat, hazırlama metodu ve kullanılması
PE20081793A1 (es) Nuevo procedimiento de preparacion de 3-metil-4-fenilisoxazolo[3,4-d]piridazin-7-(6h)-ona
AR059612A1 (es) Compuestos de piperidinil piperazina antagonistas de receptores ccr5.
ITMI20041822A1 (it) "agente terapeutico utile per il trattamento di neoplasie plasmacellulari"
AR057799A1 (es) Derivados de quinolina, composiciones farmaceuticas y uso como antitumorales